Difference between revisions of "Carcinoembryonic antigen"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
[[Image:C-cell hyperplasia in MEN 2 - CEA -- very high mag.jpg|thumb|right|CEA immunostaining in C-cell hyperplasia. (WC)]] | [[Image:C-cell hyperplasia in MEN 2 - CEA -- very high mag.jpg|thumb|right|CEA immunostaining in C-cell hyperplasia. (WC)]] | ||
'''Carcinoembryonic antigen''', abbreviated '''CEA''', is set of glycoproteins present during fetal development and associated with the gastrointestinal tract. In pathology, they are associated with gastrointestinal tract tumours; however, may be seen other tumours. | '''Carcinoembryonic antigen''', abbreviated '''CEA''', is set of glycoproteins present during fetal development and associated with the gastrointestinal tract. | ||
In [[pathology]], they are associated with gastrointestinal tract tumours; however, may be seen in other tumours. | |||
==Positive== | ==Positive== | ||
Revision as of 05:39, 2 January 2016
Carcinoembryonic antigen, abbreviated CEA, is set of glycoproteins present during fetal development and associated with the gastrointestinal tract.
In pathology, they are associated with gastrointestinal tract tumours; however, may be seen in other tumours.